Full-Time
Posted on 10/31/2025
Aseptic fill-finish equipment for sterile injectables
$80k - $110k/yr
Tacoma, WA, USA
In Person
Willing to travel domestically and internationally up to 25% of the time.
Automated Systems of Tacoma (AST) designs, builds, and services aseptic fill-finish machines for sterile injectable products and life sciences. Its equipment automates the process of filling and packaging ready-to-use nested vials, cartridges, and syringes under aseptic conditions, enabling reliable manufacturing of sterile products in pharmaceutical and biotechnology settings. The machines are designed to be flexible to accommodate different formats and regulatory requirements, and AST also offers ongoing service and support based on its five decades of experience in the field. Compared with competitors, AST emphasizes a long track record, close customer relationships, and a focus on tailoring high-automation equipment to meet stringent product and regulatory needs. The company’s goal is to provide dependable, adaptable aseptic processing solutions that help customers manufacture sterile products efficiently and in compliance with regulations.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Tacoma, Washington
Founded
1965
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Flexible Work Hours
Remote Work Options
Paid Vacation
Paid Sick Leave
Paid Holidays
Sabbatical Leave
Hybrid Work Options
Stock Options
Company Equity
401(k) Retirement Plan
401(k) Company Match
Performance Bonus
Profit Sharing
Employee Stock Purchase Plan
Relocation Assistance
Employee Referral Bonus
Student Loan Assistance
Parental Leave
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Childcare Support
Elder Care Support
Pet Insurance
Bereavement Leave
Professional Development Budget
Conference Attendance Budget
Training Programs
Tuition Reimbursement
Professional Certification Support
Mentorship Program
Wellness Program
Mental Health Support
Gym Membership
Commuter Benefits
Meal Benefits
Phone/Internet Stipend
Home Office Stipend
Legal Services
Employee Discounts
Company Social Events
AST has entered a strategic partnership with the Marchesini Group to enhance global capabilities in sterile fill-finish and drug product manufacturing. The companies said the…
TACOMA, Wash., Aug. 7, 2025 /PRNewswire/ - AST is pleased to announce that Jacob Stephen will be joining the AST Team as Chief Operations Officer at the Tacoma-headquartered drug product equipment manufacturing company.
This milestone celebration sets the stage for AST's next phase of strategic growth, anchored by its revitalized Mission, Vision, and Purpose statementsTACOMA, Wash., April 30, 2025 /PRNewswire/ -- AST marked the launch of its 60th anniversary year at INTERPHEX 2025, using the prestigious industry event as a springboard to highlight six decades of innovation. Building on the momentum of being named "Best in Show" at INTERPHEX 2024, AST entered its 60th anniversary receiving another reputable honor: the INTERPHEX Efficiency Champion award. This back-to-back recognition highlights not only AST's legacy of innovation but also its forward-looking approach to advancing excellence across the industry.AST was founded in Tacoma, Washington, in 1965. From the beginning, the company pursued a clear vision: provide advanced automated manufacturing solutions driven by a commitment to quality engineering, American ingenuity, and a customer-first approach. Now, for six decades, AST has been a leader in the advanced manufacturing space, and in 2004, the company leveraged its combined expertise and experience to begin providing flexible automation for life science applications.AST's initial success was found in innovative manufacturing solutions designed and built by a small team of engineers, including prototypes and first-of-its-kind technologies that would set new standards in what was possible with automation. These early solutions would serve as the foundation for the later technologies that AST would become recognized for
Now in 2025, AST is marking the next chapter in its mission to support the future of pharmaceutical manufacturing by expanding its portfolio with the introduction of the Shield(TM) glove integrity testing system and its digital suite of products and services with the launch of its digital twin tool - a preview of AST's' advanced solutions dedicated to digital and data integration.
Charisse Curtis has joined AST as Chief Commercial Officer, leading the Business Development, Marketing, and Communications teams.